{平台标识} {固定描述} Pfizer recently prevailed in a trademark dispute in Singapore against Merck over a vaccine brand name. The Intellectual Property Office of Singapore (IPOS) registrar concluded that the competing trademarks were “overall, dissimilar,” upholding Pfizer's position. This legal outcome may influence the pharmaceutical giants' branding strategies in the region.
Pfizer Wins Singapore Trademark Dispute with Merck Over Vaccine Brand - {财报副标题}
News Analysis
© 2026 Market Analysis. All data is for informational purposes only.